Twist Bioscience Corp reports results for the quarter ended June 30 - Earnings Summary

• Twist Bioscience Corp TWST.OQ reported a quarterly adjusted loss of 34 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $-1.47. The mean expectation of eleven analysts for the quarter was for a loss of 56 cents per share. Wall Street expected results to range from -62 cents to -51 cents per share.

• Revenue rose 17.9% to $96.06 million from a year ago; analysts expected $95.62 million.

• Twist Bioscience Corp's reported EPS for the quarter was a loss of 34 cents​.

• The company reported a quarterly loss of $20.39 million.

• Twist Bioscience Corp shares had fallen by 8.5% this quarter and lost 27.5% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 0.2% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy," 2 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is also "buy"

• Wall Street's median 12-month price target for Twist Bioscience Corp is $50.00, about 32.6% above its last closing price of $33.68

This summary was machine generated from LSEG data August 4 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)